This research study is being done to find out if elacestrant is safe and tolerable when given in combination with one of the following study drugs, approved in the treatment of advanced breast cancer: alpelisib, everolimus, palbociclib, abemaciclib, or ribociclib. Researchers will also look at what effect elacestrant (with the other study drugs) has tumor(s).